Nov 7th, 2016
Trump vs. Clinton: Who Is Better for Health-Care Stocks?
Sheryl Skolnick, director of research at Mizuho, examines risks to the health-care industry in the U.S. election and the potential for a repealing of Obamacare. She speaks with Bloomberg's David Westin on "Bloomberg Daybreak: Americas." Skolnick, her family, and firm, do not own shares of UnitedHealth Group, Mednax, Pacira Pharmaceuticals, Universal Health Services, or HCA Holdings. (Source: Bloomberg)
